Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$8,795,170
-$182,634 QoQ
Shares Held
24,288
-4.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#599
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CULLINAN ASSOCIATES INC holds $90,482,569 across 10 Drug Manufacturers - General names. AMGN ranks #3 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
177,028 | $44,959,801 | |
| 2 | ABBV |
AbbVie Inc.
|
68,800 | $17,312,832 | |
| 3 | AMGN |
Amgen Inc
This page
|
24,288 | $8,795,170 | |
| 4 | LLY |
ELI LILLY & Co
|
6,866 | $8,235,287 | |
| 5 | MRK |
Merck & Co., Inc.
|
46,620 | $5,990,670 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
40,190 | $2,315,747 | |
| 7 | PFE |
Pfizer Inc
|
51,301 | $1,235,328 | |
| 8 | NVS |
Novartis AG
|
4,700 | $736,584 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,795,170 | 24,288 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $8,977,804 | 25,516 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $10,193,415 | 31,143 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $8,873,496 | 31,444 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $9,505,983 | 34,046 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $10,755,640 | 34,523 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $9,391,901 | 36,034 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $15,434,825 | 47,903 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $15,939,324 | 51,014 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $49,647,958 | 174,620 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $44,898,573 | 155,887 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $44,843,949 | 166,855 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $46,717,892 | 210,422 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $51,235,769 | 211,937 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $53,253,936 | 202,764 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $45,819,537 | 203,281 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $49,280,171 | 202,549 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $48,150,714 | 199,118 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $44,431,799 | 197,501 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $41,074,623 | 193,156 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $41,931,825 | 172,028 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $40,022,830 | 160,857 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $38,066,704 | 165,565 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $43,122,056 | 169,665 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $40,665,801 | 172,415 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $9,412,145 | 46,427 | Shares | Sole | 2020-04-01 | |
| No filing history on record for this holder in this stock. | ||||||